Crushing Cushing's disease

McInnis, Brad L.
July 1998
Joe Weider's Muscle & Fitness;Jul98, Vol. 59 Issue 7, p18
Recounts the importance of exercise and bodybuilding in battling Cushing's disease. Symptoms of the disease; Tests conducted by an endocrinologist that led to the diagnosis; Treatment of the disease.


Related Articles

  • Psychiatric Disorders Associated with Cushing's Syndrome: Epidemiology, Pathophysiology and Treatment. Sonino, N.; Fava, G.A. // CNS Drugs;2001, Vol. 15 Issue 5, p361 

    Cushing's syndrome is caused by a chronic excess of glucocorticoids. A number of psychiatric and psychological disturbances may be associated with the condition, regardless of its aetiology. Major depression is the most common comorbid disorder. Other psychopathological aspects of Cushing's...

  • General.  // Africa Health;Jul2012, Vol. 34 Issue 5, p55 

    The article offers information related to medical studies. It mentions studies on agricultural interventions aimed to improve nutrition in children, in which most studies were underpowered to express an effect on undernutrition rates. It says that the study in Sweden that specific exercise...

  • New drug makes history in cushing's disease treatment.  // Dog World;Sep97, Vol. 82 Issue 9, p12 

    Presents information on a therapy for canine Cushing's disease, approved by the United States Food and Drug Administration. Description of canine Cushing's disease; Who developed the product; When the product was initially approved and where it is available; Information on cognitive dysfunction...

  • Investigational drugs may expand medical treatment of Cushing's syndrome. Owens, Colleen // Endocrine Today;Dec2011, Vol. 9 Issue 12, p1 

    The article focuses on mifepristone and pasireotide, two investigational drugs that have the potential to treat Cushing's syndrome, according to endocrinology experts.

  • An Overnight High-Dose Dexamethasone Suppression Test for Rapid Differential Diagnosis of Cushing's Syndrome. Tyrrell, J. Blake; Findling, James W.; Aron, David C.; Fitzgerald, Paul A.; Forsham, Peter H. // Annals of Internal Medicine;Feb86, Vol. 104 Issue 2, p180 

    Presents a study that developed a high-dose dexamethasone suppression test that can be administered overnight with a single dose and that can be used in the differential diagnosis of patients with Cushing's syndrome. Dosage of the treatment; Percentage of patients who indicated a diagnosis of...

  • Treating Cushing's disease. Jeffcoate, W.J. // British Medical Journal (Clinical Research Edition);1/23/1988, Vol. 296 Issue 6617, p227 

    Focuses on the efficacy of bilateral adrenalectomy for the treatment of Cushing's disease in Great Britain. Reduction of morbidity and mortality by using drugs to block cortisol synthesis; Comparison between hypophysectomy and selective adenomectomy; Occurrence of hypopituitarism following...

  • Treatment Options in Cushing's Disease. Rizk, Ahmed; Honegger, Juergen; Milian, Monika; Psaras, Tsambika // Clinical Medicine Insights: Oncology;2012, Issue 6, p75 

    Endogenous Cushing's syndrome is a grave disease that requires a multidisciplinary and individualized treatment approach for each patient. Approximately 80% of all patients harbour a corticotroph pituitary adenoma (Cushing's disease) with excessive secretion of adrenocorticotropin-hormone (ACTH)...

  • Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease. Feelders, Richard A.; De Bruin, Christiaan; Pereira, Alberto M.; Romijn, Johannes A.; Netea-Maier, Romana T.; Hermus, Ad R.; Zelissen, Pierre M.; Van Heerebeek, Ramona; De Jong, Frank H.; Van der Lely, Aart-Jan; De Herder, Wouter W.; Hofland, Leo J.; Lamberts, Steven W. // New England Journal of Medicine;5/13/2010, Vol. 362 Issue 19, p1846 

    A letter to the editor is presented about a study on the impact of pasireotide on the treatment of Cushing's disease.

  • Metyrapone in long-term management of Cushing's disease. Jeffcoate, W.J.; Rees, Lesley H.; Tomlin, Susan; Jones, A.E.; Edwards, C.R.W.; Besser, G.M. // British Medical Journal;7/23/1977, Vol. 2 Issue 6081, p215 

    Reports the use of metyrapone in the long-term management of Cushing's disease. Features of the disease; Side effects of metyrapone; Recommendations to use metyrapone as an adjunct to definitive treatment of patients with Cushing's syndrome.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics